Neuroblastoma Dokter Terbaik di Turquia - TOP-13 dokter

Prof. Yeşim (Yesim) Yıldırım — Ahli Onkologi Medis di Anadolu Medical Center (sejak 2011). Spesialis bersertifikat ESMO, Profesor sejak 2021, penulis lebih dari 80 publikasi ilmiah. Dilatih di pusat-pusat terkemuka — Rambam (Israel) dan Mount Vernon (Inggris). Menangani kanker payudara, paru-paru, dan gastrointestinal (GI), serta melanoma dan sarkoma; menggunakan imunoterapi dan terapi target.

Alasan pasien memilih Dr. Yeşim Yıldırım:

• 20+ tahun praktik klinis; Profesor Onkologi Medis sejak 2021.
• 80+ publikasi teruji sejawat dalam biologi tumor, imunoterapi, dan terapi target — rencana pengobatan didasarkan pada bukti terkini.
• Sertifikasi ESMO — dari masyarakat onkologi terkemuka di Eropa — mengonfirmasi kualifikasi tinggi dan pelatihan berkelanjutan sesuai standar internasional.

Pendidikan

• Fakultas Kedokteran Ege 1978
• Spesialisasi di bidang Pediatri 1982
• Subspesialisasi Onkologi Pediatrik 2002 (Fakultas Kedokteran EU)
• Hematologi dan Onkologi Pediatrik 2012 (Fakultas Kedokteran EU)
• Wakil Kepala Klinik 1988 Tepecik EAH
• Kepala Klinik 1993 Tepecik EAH
• Asosiasi Profesor 1995
• Profesor 2002
• Anggota Fakultas Fakultas Kedokteran Ege U. 1998 – 2022
• Departemen Kedokteran Anak Fakultas Kedokteran EU 2009-2018
• Anggota Dewan Perencanaan dan Koordinasi Pendidikan Tepecik (1993-1998)
• Ketua Komite Etik Rumah Sakit SSI Tepecik (1996-1998)
• Masyarakat Hematologi Anak Turki "Wakil Ketua Kelompok Kerja Transplantasi Sumsum Tulang" (2002-2006)
• Masyarakat Hematologi Anak Turki "Kelompok Kerja Transplantasi Sumsum Tulang" (2006-2008)
• Masyarakat Hematologi Anak Turki - Bertanggung jawab atas Sistem Registri Data "Online" Transplantasi Sumsum Tulang 2007-sekarang.
• Ketua Komisi Kedokteran Regeneratif dan Sel Punca Universitas Ege, 2011-2021

Keanggotaan Institusi

• Asosiasi Medis Turki Cabang İzmir dan Kocaeli
• Asosiasi Pediatri Nasional Turki - İzmir
• Grup Eropa untuk Transplantasi Sumsum Tulang (EBMT); Unit Transplantasi Sumsum Tulang Pediatrik Universitas Ege terakreditasi oleh Grup Eropa untuk Transplantasi Sumsum Tulang (EBMT) pada Juni 2007.
• Masyarakat Hematologi Anak Turki - Anggota Dewan selama dua periode (2005-2009)
• Masyarakat Hematologi Turki - Anggota Dewan selama dua periode (2001/2005)
• Asosiasi Onkologi Pediatrik Turki
• Yayasan Transplantasi Sumsum Tulang (KITVAK) Anggota Dewan Pengawas

Unit yang Didirikannya                        

1- Klinik Onkologi Pediatrik Rumah Sakit SSI Tepecik (1990) 
2- Unit Transplantasi Sumsum Tulang Pediatrik Rumah Sakit SSI Tepecik (1992) 
3- Unit Transplantasi Sumsum Tulang Pediatrik Fakultas Kedokteran EU (1998) 
4- PENDIRI JURNAL PENELITIAN PEDIATRIK, 2014; aplikasi SCI dilakukan pada 2022. 

Unit Transplantasi yang Dia Berkontribusi dalam Pendirian                        

1. Unit Transplantasi Sumsum Tulang Pediatrik İzmir BUÇH EAH (2019) 
2. Unit Transplantasi Sumsum Tulang Pediatrik Ümraniye EAH (2020) 
3. Unit Transplantasi Sumsum Tulang Pediatrik Kanuni Sultan Süleyman EAH (2020) (Dipindahkan ke Çam Sakura EAH)

Penghargaan

• Parameter trombotik pada pasien transplantasi sel punca sumsum tulang, Kongres Hematologi Pediatrik, Trabzon 2003
• Antigen CD133 dalam Sel Punca: Kongres Hematologi Pediatrik 2005. Penghargaan penelitian
• Peran reseptor Toll seperti pada pasien neutropenik febril, penghargaan poster terbaik. Kongres Hematologi Turki 2008, Çeşme-İzmir
• Kegiatan transplantasi sel punca pediatrik nasional- Penghargaan presentasi lisan kedua, Kongres Transplantasi Sel Punca Masyarakat Hematologi Turki, 2022, Antalya

Publikasi

Kansoy S. "Transplantasi Sumsum Tulang dan Sel Punca Kesehatan Anak dan Penyakit, edisi pertama, Percetakan Fakultas Kedokteran EU, 1999, İzmir

Kansoy S. Transplantasi sumsum tulang pada Thalassemia Major III. Buku Hari Thalassemia Aegea, 2000, Izmir

Kansoy S. Standar Pusat KIT Pediatrik di Turki. Leukemia Akut Anak, Antalya 2000: 73-5

Kansoy S. Efek Samping Jangka Panjang pada Anak. Edisi khusus Jurnal Transplantasi Sumsum Tulang Klinik Turki. 2003

Kansoy S. Aplikasi Sel Punca dalam Transplantasi Sumsum Tulang dan Sel Punca. Buku Kursus Keperawatan Onkologi Pediatrik, İzmir, 2005

Kansoy S. Darah Tali Pusat sebagai Sumber Sel Punca. Edisi Khusus Sel Punca. Klinik Turki, 2008

Kansoy S. Transplantasi Sel Punca pada Limfoma. Buku Pediatri Umum, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Transplantasi Sumsum Tulang pada Anak. Pediatri, 2014 dan 2017

Kansoy S. Rhabdomyosarcoma. Pediatri, 2014 dan 2017

Kansoy S. Pendekatan kepada Anak dengan Kanker Berdasarkan Temuan Klinis. Pediatri, 2014 dan 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Penyakit Onkologis. Pediatri (Ed. A. Cura), 641-672, Percetakan Universitas Ege, İzmir, 1999.  (1.05 poin)

Kansoy S, M.Kantar. Pemeriksaan Kepala, Wajah, dan Mata. Pemeriksaan Fisik Prostetik Pediatrik dan Informasi Gejala (Ed. A.Cura)

Kantar M. Masalah Darurat Metabolik dalam Onkologi. Darurat Onkologi dan Perawatan Dukungan pada Anak (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Transplantasi Darah Tali Pusat di Turki. HEMATOLOGIST, 2016

Kansoy S. Tumor Sistem Saraf Pusat pada Anak Pediatri, 2014 dan 2017

Leukemia mieloblastik akut pada anak dan pengobatannya. Buku Ajar Onkologi Pediatrik, Turki Poplack, 2020

Kegiatan transplantasi sel punca pediatrik nasional, 2020

Indikasi transplantasi sel punca anak, Klinik Turki - Buku Internasional 2020

Selain studi dan makalah di jurnal internasional yang diterbitkan dalam jumlah besar, dia terlibat dalam studi multinasional internasional di beberapa jurnal dengan nilai dampak tinggi.

Assoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.

MEDICAL AREAS OF INTEREST

Healthy baby follow-up and vaccinations

Lymph node enlargement

Pediatric patients with anemia (anemia)

Leukemia

Lymphoma

Bone Marrow Transplant

ITP

Thalassemias

Hemophiliacs

Solid tumors

Hemangioma

Childhood blood disorders

Children with frequent infections

Fever of unknown origin

Malnutrition in children

Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.

Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Pediatric Hematology and Oncology

Education

MSc Faculty of Medicine (ING) Hacettepe University 1991-1997
Specialization Department of Pediatrics Dicle Universityniversitesi 1997-2002
Minor Cerrahpaşa Faculty of Medicine Pediatric Hematology & Oncology Department Istanbul University 2006-2009
Bone Marrow Transplant Unit MP Göztepe Hospital 2012-2013

Experience

Assistant Professor
Afyon Kocatepe University/Faculty of Medicine/Internal Medical Sciences
2003-2009 Department/ÇDepartment of Pediatrics)

Assistant Professor
Istanbul University/Cerrahpaşa Faculty of Medicineltesi/Internal Medical Sciences
2006-2009 Department of Pediatrics)

Pediatric Hematology Specialist Diyarbakır Children's Hospital, Pediatric Hematology compulsory service 2009-2012
Transfer Ünitesi Assistant Hematology Specialist Private Medical Park Göztepe Hospital Bone Marrow Transplant Unit Assistant Responsible Pediatric Hematology Specialist
2012-2013

Assistant Professor
Akdeniz University / Faculty of Medicine / Department of Internal Medical Scienceslümü/Department of Pediatrics)
2013-2014

Assistant Professor Marmara University/Faculty of Medicine/Department of Internal Medical Sciences/Department of Pediatrics) 2014-2024

Scientific Memberships

Turkish Society of Hematology
Turkish Pediatric Hematology Association
Marmara Pediatric Association
Turkish Pediatric Society
Istanbul Medical Chamber
EBMT (European Bone Marrow Transplantation)

Dr. Metin Demirkaya is a specialist in Pediatric Oncology. He earned his medical degree from Istanbul University Cerrahpaşa School of Medicine between 1993 and 1999. He completed his Pediatrics residency and Pediatric Oncology residency at Bursa Uludag University from 1999 to 2010.

Dr. Demirkaya has worked at leading centers such as GATA Pediatric Hematology-Oncology-Bone Marrow Transplantation Centre and Istanbul Kanuni Sultan Süleyman Education and Research Hospital. He became an Assistant Professor in 2013. In 2019, he was appointed Professor of Medicine in Pediatric Oncology at Medicana Bursa Hospital.

Dr. Demirkaya is known for his clinical skills and leadership in pediatric cancer care and bone marrow transplantation. He has made important contributions to research and has received recognition in his field.

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.